Recruiting NCT07527143

Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer

— Observational Endometrial Carcinoma

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied: The protocol lists: Non-Interventional Study.
Who it may be relevant to: Registry conditions: Endometrial Carcinoma. Basic parameters: from 45 years · Female.
What needs checking: Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place: United States
Next step: Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

This study evaluates how women feel about using DNA from a vaginal fluid collection for early detection of endometrial cancer.

Acceptability of vaginal fluid collection for a DNA-based early detection endometrial cancer test [Time frame: Baseline (30-minute virtual interview)]

Self-identified Black individuals ≥ 45 years with an intact uterus
Assigned female sex at birth
Experience with abnormal uterine or post-menopausal bleeding (defined as vaginal bleeding between periods, heavy vaginal bleeding, vaginal bleeding after menopause, and/or red, brown, or pink colored vaginal discharge after menopause)
Willing to participate in a 45-minute virtual interview

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

United States · 1 center

NCT: NCT07527143 · 25-011120